PerkinElmer Life and Analytical Sciences, a global leader in life science research, drug discovery and cellular science, today announced the appointment of Martina Bielefeld-Sevigny, Ph.D., as vice president and general manager, drug discovery and research reagents. In this role, she will be responsible for driving expansion of the reagents portfolio for its Bio-discovery business.

Bielefeld-Sevigny, who most recently served as director, Molecular Pharmacology, within PerkinElmer Bio-discovery’s reagents business, and led the Company’s Center of Excellence in Montreal, Canada, brings over 20 years of distinguished life sciences industry experience to her new position, with both a strong commercial and technical background.

“Martina is a proven scientific, operational and business leader and has demonstrated outstanding results in her R&D role in recent years,” said Richard Eglen, Ph.D., president, Bio-discovery, PerkinElmer. “We are confident that her commitment to developing and leading high performance initiatives will help to grow PerkinElmer’s role as an industry leader in providing integrated solutions to meet emerging customer needs.”

“It has been a pleasure to be part of the exciting scientific and business innovations led by PerkinElmer’s Bio-discovery business,” said Bielefeld-Sevigny, “I look forward to continuing our successful efforts to expand our reagent offerings in drug discovery and academic research.”

Prior to joining PerkinElmer in 2004, Bielefeld-Sevigny held the position of director, Process Development at DSM Biologics of Montreal. Before DSM Biologics, Bielefeld-Sevigny held a series of posts at Pharmacia Biotech, Inc., in Freiburg, Germany, Uppsala, Sweden, and Montreal, Canada, between 1990 and 1998, lastly serving as Scientific Affairs Manager.

Bielefeld-Sevigny received her Ph.D. from the Institute for Microbiology, Dusseldorf, Germany, and is the author of numerous scientific publications.